{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0000925741","name":"BioCardia, Inc.","summary":"BioCardia, Inc. is a clinical-stage company developing cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its CardiAMP autologous mononuclear cell therapy platform targets ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina from chronic myocardial ischemia. Its allogeneic mesenchymal stem cell (MSC) platform targets ischemic inflammatory HFrEF and ARDS. Products are enabled by the Helix transendocardial biotherapeutic delivery system for minimally invasive catheter-based intramyocardial delivery.","people":[],"products":[{"name":"CardiAMP Cell Therapy System","type":"platform","description":"Autologous mononuclear cell therapy system comprising a cell potency screening test, point-of-care cell processing platform, and biotherapeutic delivery system for ischemic HFrEF and chronic myocardial ischemia."},{"name":"CardiALLO","type":"platform","description":"Allogeneic MSC off-the-shelf investigational cell therapy targeting ischemic inflammatory HFrEF and designed for all 1.7 million HFrEF patients."},{"name":"Helix Transendocardial Biotherapeutic Delivery System","type":"hardware","description":"Minimally invasive catheter-based system enabling intramyocardial delivery of biotherapeutics to the heart; also licensed to partners for development services."}],"partnerships":[{"partner_name":"Unspecified partners","partnership_type":"development","description":"BioCardia partners its Helix therapeutic delivery platform and provides development services to others seeking to develop biotherapeutic interventions for local delivery to the heart.","start_date":null}],"affiliations":[],"origin":{"leaf":"14c9b3217551af46492feab2ed5501a5403f54f33e987c37525aa1877f670974","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"1ab0eb3f3e7b9037317d33b8ceb9868499b609fd9c25977e75781c3bcc066e6e","parent":"e8c38fc8d86ce554346fb52f6c92f5cbcf1088617099d2389a32078eb70b5871","source":"0001437749-26-009587","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":264,"hourly_limit":500,"remaining":236,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}